New Chairman Positions Sinopharm As Pharmaceutical Platform Of State-Owned Enterprises
This article was originally published in PharmAsia News
State-owned Assets Supervision and Administration Commission of the State Council recently appointed Song Zhiping, present chairman of the China National Building Material Group, as external director and chairman of Sinopharm. The move is regarded as a hallmark event for SASAC to push for a "professional chairman." Song was the key person who led CNBM public, while Sinopharm Medicine Holdings is preparing for a listing in Hong Kong and looking for someone with such experience. Song has mapped out the strategic direction for Sinopharm - the company will adhere to its main business while leveraging on market capital. This will help accelerate industry resources integration to forge a globally competitive pharmaceutical platform for state-owned enterprises. (Click here for more - Chinese Language)
You may also be interested in...
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.